Sept 21, 2017

Cogentis is named winner at GTC Bio Pitch

Cogentis took home 1st place at inaugural new company/technology pitch at the GTC CNS Diseases Summit in Boston, MA 

Read more about the CNS Disesases Summit here.


July 10, 2017

Cogentis is named a 43North Semifinalist

Cogentis has been named 1 of 134 semifinalists in the prestigious 43North accelerator. 

Read 43North's announcement here and a list of other semifinalists here.


October 14, 2015

Cogentis is a Top26 MassChallenge Finalist

Cogentis has been named 1 of 26 finalists (out of over 1500+ startups) in the prestigious MassChallenge accelerator. Support Cogentis at this year's MC Awards Ceremony held in Boston on October 28.

Read MassChallenge's announcement here.


June 26, 2015

Cogentis wins a Cydan scholarship

We are proud to announce that Cydan Development, a sponsor of the prestigious MassChallenge accelerator, has awarded one of its five MassChallenge scholarships to Cogentis Therapeutics.

Read Cydan's announcement here.


May 21, 2015

Cogentis wins the Neuro Startup Challenge

Cogentis was selected as the winner of the Neuro Startup Challenge sponsored by the Center for Advancing Innovation, Heritage Provider Network and the National Institutes of Health

Read NSUC announcement here.


April 15, 2015

Cogentis advances to Finals in OneStart Competition

Cogentis was selected as 1 of 10 biotech teams (out of 300+ original teams) to move on to the finalist stage in the One Start Americas competition. The competition is sponsored by Oxbridge Biotech Roundtable and SR-One (VC arm of GSK).

Read OneStart announcement here.

View our OneStart semi-finalist video here.